Recent Analysis Shows COUPA SOFTWARE, Galmed Pharmaceuticals, Sunworks, Murphy, Diversicare Healthcare Services, and Pro-Dex Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of COUPA SOFTWARE (NASDAQ:COUP), Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD), Sunworks, Inc. (NASDAQ:SUNW), Murphy USA Inc. (NYSE:MUSA), Diversicare Healthcare Services Inc. (NASDAQ:DVCR), and Pro-Dex, Inc. (NASDAQ:PDEX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

COUP DOWNLOAD: http://Fundamental-Markets.com/register/?so=COUP
GLMD DOWNLOAD: http://Fundamental-Markets.com/register/?so=GLMD
SUNW DOWNLOAD: http://Fundamental-Markets.com/register/?so=SUNW
MUSA DOWNLOAD: http://Fundamental-Markets.com/register/?so=MUSA
DVCR DOWNLOAD: http://Fundamental-Markets.com/register/?so=DVCR
PDEX DOWNLOAD: http://Fundamental-Markets.com/register/?so=PDEX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine COUPA SOFTWARE (NASDAQ:COUP), Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD), Sunworks, Inc. (NASDAQ:SUNW), Murphy USA Inc. (NYSE:MUSA), Diversicare Healthcare Services Inc. (NASDAQ:DVCR), and Pro-Dex, Inc. (NASDAQ:PDEX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 12th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

COUPA SOFTWARE (COUP) REPORT OVERVIEW

COUPA SOFTWARE's Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, COUPA SOFTWARE reported revenue of $61.65MM vs $44.55MM (up 38.38%) and analysts estimated basic earnings per share -$0.24 vs -$0.26. For the twelve months ended January 31st, 2018 vs January 31st, 2017, COUPA SOFTWARE reported revenue of $186.78MM vs $133.78MM (up 39.62%) and analysts estimated basic earnings per share -$0.83 vs -$1.88. Analysts expect earnings to be released on December 3rd, 2018. The report will be for the fiscal period ending October 31st, 2018. The reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is -$0.89 and is expected to report on March 11th, 2019.

To read the full COUPA SOFTWARE (COUP) report, download it here: http://Fundamental-Markets.com/register/?so=COUP

-----------------------------------------

GALMED PHARMACEUTICALS LTD. (GLMD) REPORT OVERVIEW

Galmed Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Galmed Pharmaceuticals reported revenue of $1.50MM vs $0.27MM (up 449.45%) and analysts estimated basic earnings per share -$0.05 vs -$0.23. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Galmed Pharmaceuticals reported revenue of $1.09MM vs $0.47MM (up 132.33%) and analysts estimated basic earnings per share -$0.98 vs -$1.49. Analysts expect earnings to be released on March 12th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.27. The estimated EPS forecast for the next fiscal year is -$1.00 and is expected to report on March 12th, 2019.

To read the full Galmed Pharmaceuticals Ltd. (GLMD) report, download it here: http://Fundamental-Markets.com/register/?so=GLMD

-----------------------------------------

SUNWORKS, INC. (SUNW) REPORT OVERVIEW

Sunworks' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Sunworks reported revenue of $18.28MM vs $18.80MM (down 2.75%) and analysts estimated basic earnings per share -$0.01 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Sunworks reported revenue of $77.45MM vs $86.42MM (down 10.38%) and analysts estimated basic earnings per share -$0.32 vs -$0.46. Analysts expect earnings to be released on March 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.15. The estimated EPS forecast for the next fiscal year is $0.08 and is expected to report on March 27th, 2019.

To read the full Sunworks, Inc. (SUNW) report, download it here: http://Fundamental-Markets.com/register/?so=SUNW

-----------------------------------------

MURPHY USA INC. (MUSA) REPORT OVERVIEW

Murphy's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Murphy reported revenue of $3,788.00MM vs $3,236.30MM (up 17.05%) and basic earnings per share $1.40 vs $1.92 (down 27.08%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Murphy reported revenue of $12,826.55MM vs $11,594.55MM (up 10.63%) and analysts estimated basic earnings per share $6.85 vs $5.64 (up 21.45%). Analysts expect earnings to be released on January 30th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.03. The estimated EPS forecast for the next fiscal year is $4.71 and is expected to report on January 30th, 2019.

To read the full Murphy USA Inc. (MUSA) report, download it here: http://Fundamental-Markets.com/register/?so=MUSA

-----------------------------------------

DIVERSICARE HEALTHCARE SERVICES INC. (DVCR) REPORT OVERVIEW

Diversicare Healthcare Services' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Diversicare Healthcare Services reported revenue of $141.43MM vs $146.38MM (down 3.38%) and analysts estimated basic earnings per share -$1.15 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Diversicare Healthcare Services reported revenue of $574.79MM vs $426.06MM (up 34.91%) and analysts estimated basic earnings per share -$0.77 vs -$0.29. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full Diversicare Healthcare Services Inc. (DVCR) report, download it here: http://Fundamental-Markets.com/register/?so=DVCR

-----------------------------------------

PRO-DEX, INC. (PDEX) REPORT OVERVIEW

Pro-Dex's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Pro-Dex reported revenue of $6.92MM vs $5.16MM (up 33.98%) and analysts estimated basic earnings per share $0.31 vs $0.15 (up 106.67%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Pro-Dex reported revenue of $22.47MM vs $21.94MM (up 2.38%) and analysts estimated basic earnings per share $0.38 vs $1.26 (down 69.84%). Analysts expect earnings to be released on February 14th, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full Pro-Dex, Inc. (PDEX) report, download it here: http://Fundamental-Markets.com/register/?so=PDEX

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.